MYEOV2 Activators
MYEOV2 activators form a specific class of chemical agents that are designed to interact with and enhance the activity of the MYEOV2 protein. MYEOV2 stands for myeloma overexpressed 2, which suggests its initial identification in certain cellular contexts; however, its biological function is not thoroughly characterized. This class of activators is predicated on the understanding that proteins like MYEOV2 play a role in cellular processes, potentially involving regulation of gene expression, signal transduction, or other intracellular activities. The activators are engineered to bind to MYEOV2 and modulate its function, which is achieved by inducing conformational changes or affecting interaction with other molecular partners. The precise mode of action of these activators is dependent on the structure of MYEOV2, particularly the domains that are amenable to small molecule interaction. The aim is to design activators that are both selective for MYEOV2 and capable of influencing its activity in a predictable manner.
The development of MYEOV2 activators requires a multi-faceted approach that integrates knowledge from biochemistry, molecular biology, and chemistry. Initial steps often involve elucidating the three-dimensional structure of MYEOV2 or identifying key functional domains that are amenable to modulation by small molecules. Subsequent efforts focus on the design, synthesis, and optimization of compounds that can interact with these domains. Advanced techniques such as high-throughput screening, computational docking, and structure-activity relationship (SAR) analysis are commonly utilized to discover and refine molecules that can serve as effective activators. Each compound is evaluated for its ability to bind to MYEOV2 and affect its molecular function, with a strong emphasis on achieving specificity to prevent off-target effects. Through iterative cycles of design and testing, chemical entities are fine-tuned to enhance their interaction with MYEOV2, with the ultimate goal of precisely modulating the protein's activity within its native cellular environment.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin raises intracellular cAMP levels, which can lead to the activation of protein kinase A (PKA). PKA can then phosphorylate other proteins that may interact with or regulate MYEOV2, leading to its enhanced functional activity, particularly in pathways where MYEOV2 is involved in cellular signaling related to growth and differentiation. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-specific inhibitor of phosphodiesterases, which leads to increased cAMP levels by preventing its breakdown. The consequent rise in cAMP can enhance the activation of PKA, thereby potentially increasing the functional activity of MYEOV2 through phosphorylation events or the modulation of signaling pathways that MYEOV2 is a part of. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), which can modulate multiple signaling pathways, some of which may include MYEOV2 participation. PKC activation can lead to altered cell proliferation and differentiation processes, potentially enhancing the functional role of MYEOV2 in these pathways. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore which increases intracellular calcium levels, thereby activating calcium-dependent signaling pathways. MYEOV2, if involved in calcium signaling, would have its functional activity enhanced as a result of the increased activation of these pathways. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate interacts with its receptors to activate signaling pathways that can lead to cytoskeletal rearrangements and influence cell adhesion and motility. If MYEOV2 is involved in these processes, its activity could be enhanced by the activation of these pathways. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of MEK, which is part of the MAPK/ERK pathway. By inhibiting MEK, PD98059 can alter the pathway's activity and, if MYEOV2 is influenced by this pathway, could lead to enhanced MYEOV2 activity either through the reduction of negative feedback loops or by modifying the pathway dynamics that MYEOV2 is a part of. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a specific inhibitor of p38 MAP kinase. By inhibiting p38, it can modulate stress response pathways. If MYEOV2 is involved in responding to cellular stress or is regulated by p38 activity, then SB203580 could indirectly enhance MYEOV2 activity by shifting signaling in favor of pathways where MYEOV2 has a functional role. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin gallate (EGCG) is a polyphenol that can inhibit various kinases. If MYEOV2 is regulated by any of these kinases, inhibition by EGCG could lead to enhanced activity of MYEOV2 by reducing inhibition or by modifying signaling pathways that intersect with the functional role of MYEOV2. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to increased cytosolic calcium levels. This can activate calcium-dependent signaling cascades, potentially enhancing the activity of MYEOV2 if it is responsiveBased on the provided "naming instructions," here is the requested table for Question 1 using the protein name "Protein K" and the gene name "GENEK": | ||||||